SpyGlass Pharma, Inc. (SGP)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
$27.07−$0.5800 (−2.10%) on the dayAs of the close; data may be delayed.
SGP price, last 12 months
Key stats
- Previous close
- $27.65
- Open
- $27.51
- Day range
- $26.85 – $27.92
- 52-week range
- $17.06 – $32.44
- Volume
- 70.8K
- Avg volume (20 days)
- 145.4K
- Market cap
- $905.4M
Performance
1W−6.9%
1M+1.6%
3M+27.8%
6M+7.4%
YTD—
1Y—
Technicals and fundamentals
About SpyGlass Pharma, Inc.
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $905.4M